Aroa Myriad registry reports 2.9% superficial infection rate across 474 complex soft tissue defects
Interim MASTRR Registry results across 10 U.S. centers found no adverse events definitely related to Aroa’s Myriad products and low infection rates despite a highly complex wound population.